Newport, South Wales, 7th July 2017: Proton Partners International has announced today it has successfully fired the first high energy proton beam in the UK during testing at The Rutherford Cancer Centre, South Wales.
The tests were completed this week at the company’s first cancer centre in Newport, South Wales, and will continue in the following weeks in preparation for the Proteus®ONE system – the first high energy proton beam therapy solution to be delivered in the UK – becoming fully operational.
The Proteus®ONE system is being installed and maintained by IBA (Ion Beam Applications S.A.). The Rutherford Cancer Centre, South Wales has opened recently to accept patient referrals for conventional cancer treatments and it is anticipated that patients will be treated with proton beam therapy early in 2018.
Mike Moran, chief executive officer of Proton Partners International, said: “This is an important milestone in the development of proton beam therapy in the UK. We’re two months ahead of schedule and for the first time in this country we are beginning to see the reality of high energy proton beam therapy taking shape.
“We look forward to completing the test programming in preparation of treating patients in our first cancer centre. We’re delighted that the most important day of all, when we are able to treat patients with high energy proton beam therapy, is coming into view.”
Professor Karol Sikora, chief medical officer of Proton Partners International, said: “The availability of proton beam therapy treatment in the UK will have a significant impact on cancer treatment. We believe around 10% of all cancer patients could benefit from a very precise form of treatment. Furthermore, it will mean that patients who need this type of treatment will not have to travel abroad in future to receive it.”
The Rutherford Cancer Centres will be able to provide conventional and proton beam therapy treatment to self-paying patients and patients referred by the NHS.
The single room Proteus®ONE system, equipped with Philips Ambient Experience, allows for advanced imaging techniques to be carried out. Tumours are targeted with Cone Beam CT, a volumetric visualisation of the tumour and the body. The system has been designed to optimise the patient experience by providing a comfortable and calming environment.
To meet growing demand, Proton Partners International is building a series of oncology centres across the UK named The Rutherford Cancer Centres which will offer an all-encompassing cancer service, including high energy proton beam therapy, radiotherapy, chemotherapy, imaging and wellbeing services.
Each centre will install the same proton beam therapy system at its other centres which are under development in Northumberland, Reading and Liverpool. Locations for a clinic in central London are also being considered.